How were Presbia's earnings last quarter?

Presbia PLC (NASDAQ:LENS) issued its quarterly earnings results on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.07. The medical instruments supplier earned $0.01 million during the quarter, compared to analyst estimates of $0.04 million. Presbia had a negative trailing twelve-month return on equity of 414.02% and a negative net margin of 36,604.35%.

What other stocks do shareholders of Presbia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Presbia investors own include Ritter Pharmaceuticals (RTTR) , AcelRx Pharmaceuticals (ACRX) , Allena Pharmaceuticals (ALNA) , Bellatrix Exploration (BXE) , Second Sight Medical Products (EYES) , Lilis Energy (LLEX) , Marinus Pharmaceuticals (MRNS) , Novavax (NVAX) , Ampliphi Biosciences (APHB) and ArQule (ARQL) .

When did Presbia IPO?

Presbia (LENS) raised $50 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,200,000 shares at $11.00-$13.00 per share. Jefferies served as the underwriter for the IPO.

NASDAQ:LENS

Presbia (LENS) Stock Price, News & Analysis

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)

Free LENS Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $0.07
▼
$0.32
52-Week Range: N/A

Volume: N/A
Average Volume: 122,366 shs
Market Capitalization: $258,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Ad Wall Street Star

This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

About Presbia Stock (NASDAQ:LENS)

Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.

Ad Wall Street Star

This Apple-like Innovator is Revolutionizing Healthcare

Click here to learn more about the booming eHealth industry

LENS Stock News Headlines

February 7, 2024 | forbes.com

12 Of The Best Contact Lenses, According To An Ophthalmologist

February 1, 2024 | time.com

Contact Lens King Coupons

January 16, 2024 | bbc.co.uk

Real and virtual images

April 29, 2023 | forbes.com

If You Want To Wear Colored Contact Lenses, FDA Has A Warning

March 31, 2023 | cnet.com

Never Do These 13 Things With Contact Lenses

March 20, 2023 | bbc.co.uk

Types of lens

March 16, 2023 | bbc.co.uk

Convex and concave lenses

February 24, 2023 | dailymail.co.uk

I fell asleep with contact lenses in and a flesh-eating bug ate my EYE

February 17, 2023 | techcrunch.com

Snap introduces ray tracing technology for its AR lenses to enhance realism

January 6, 2023 | finance.yahoo.com

CCTV Lens Market valued at 1.5 Billion in 2022, is set to witness a growth of 8.93% in the next 7 years

October 15, 2022 | dailymail.co.uk

World's largest camera with a five-foot-wide lens powerful enough to spot a golf ball from 15 miles away is unveiled by astronomers - and will be used to capture the night sky ...

September 25, 2022 | thetimes.co.uk

Reusable contact lenses ‘raise risk of eye infection’

September 25, 2022 | nypost.com

Reusable contact lenses could cause blindness: study

May 4, 2022 | yahoo.com

Corneal Implants Market to hit USD 495 Million by 2028, Says Global Market Insights Inc.

November 13, 2021 | marketwatch.com

Presbyopia Correction Devices Market Report Leading Companies, Spotting Market Dynamics and Business Opportunities 2022 to 2027

See More Headlines

Company Calendar

Last Earnings: 8/12/2016
Today: 5/20/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & Medical Instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:LENS
CUSIP: N/A
CIK: 1591096
Web: www.presbia.com
Phone: (531) 551-1487
Fax: N/A
Employees: 24
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,410,000.00
Net Margins: -36,604.35%
Pretax Margin: N/A
Return on Equity: -414.02%
Return on Assets: -195.56%

Debt

Debt-to-Equity Ratio: 1.24
Current Ratio: 2.88
Quick Ratio: 2.82

Sales & Book Value

Annual Sales: $20,000.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.09 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 17,230,000
Free Float: N/A
Market Cap: $258,000.00
Optionable: Not Optionable
Beta: 2.57

Key Executives

Zohar Loshitzer
Executive Chairman & Chief Executive Officer
Casey Lind
Chief Operating Officer

Key Competitors

View All Competitors

LENS Stock Analysis - Frequently Asked Questions

How were Presbia's earnings last quarter?: Presbia PLC (NASDAQ:LENS) issued its quarterly earnings results on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.07. The medical instruments supplier earned $0.01 million during the quarter, compared to analyst estimates of $0.04 million. Presbia had a negative trailing twelve-month return on equity of 414.02% and a negative net margin of 36,604.35%.
What other stocks do shareholders of Presbia own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Presbia investors own include Ritter Pharmaceuticals (RTTR), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Bellatrix Exploration (BXE), Second Sight Medical Products (EYES), Lilis Energy (LLEX), Marinus Pharmaceuticals (MRNS), Novavax (NVAX), Ampliphi Biosciences (APHB) and ArQule (ARQL).
When did Presbia IPO?: Presbia (LENS) raised $50 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,200,000 shares at $11.00-$13.00 per share. Jefferies served as the underwriter for the IPO.

This page (NASDAQ:LENS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Presbia (LENS) Stock Price, News & Analysis

About Presbia Stock (NASDAQ:LENS)

LENS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

LENS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info